22nd September 2020
BCI PhD student wins People’s Choice Award at thesis competition national final Congratulations to Vinaya Srirangam Nadhamuni, Clinical Research Fellow at Barts Cancer Institute (BCI), Queen Mary University of London, […]
Read more18th September 2020
An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Professor Tom Powles.
Read more16th September 2020
Results from a phase I clinical trial led by Professor Peter Szlosarek were recently published in JTO Clinical and Research Reports. The trial was investigating the safety and efficacy of a new drug combination for the treatment of mesothelioma. We spoke to Professor Szlosarek to find out more about the trial, and how the drug combination may be able to help patients with mesothelioma.
Read more15th September 2020
Professor John Gribben, Lead for the Centre for Haemato-Oncology at Barts Cancer Institute and Consultant Haematologist at Barts Health NHS Trust, is part of a new BBC Two series called The Diagnosis Detectives. Professor Gribben is one of a panel of 12 of the UK’s leading medical experts who have been assembled to diagnose patients with life-changing symptoms that have puzzled other doctors and remained undiagnosed.
Read more9th September 2020
A new study has identified molecular characteristics in ‘normal-looking’ tissues surrounding breast tumours that may indicate whether breast cancer is likely to return following surgical removal of the tumour.
Read more17th August 2020
For women at high risk of ovarian cancer, standard preventive practice is to offer removal of both the fallopian tubes and ovaries, but the surgery induces menopause in women who have not yet reached this stage of life. A proposed alternative two step surgical protocol, which delays the induced menopause caused by the removal of the ovaries, is highly acceptable to this premenopausal group of women.
Read more